Intestinal transport of β-lactam antibiotics:: Analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux

被引:172
作者
Bretschneider, B
Brandsch, M
Neubert, R
机构
[1] Univ Halle Wittenberg, Inst Pharmaceut & Biopharmaceut, Dept Pharm, D-06120 Halle, Germany
[2] Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany
关键词
PEPT1; peptide transport; beta-lactam antibiotics; Caco-2; cells; cephalosporins; penicillins;
D O I
10.1023/A:1018814627484
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. This study on the intestinal transport of p-lactam antibiotics was undertaken to investigate the correlation between cellular transport parameters and the bioavailability. Methods. Transport of 23 beta-lactam antibiotics was characterized by measuring their ability to inhibit the uptake of glycylsarcosine into Caco-2 cells, their uptake into the cells and their total flux across the cell monolayers. Results. Ceftibuten and cyclacillin were recognized by PEPT1 with affinity constants comparable to those of natural dipeptides (K-i = 0.3 and 0.5 mM, respectively). Cefadroxil, cefamandole, cephradine, cefaclor, cefuroxime-axetil, cefixime, cephalotin, cephalexin and ampicillin also interacted with PEPT1 (K-i = 7-14 mM). In contrast, cefapirin, cefodizime, cefuroxime, cefmetazole, ceftazidime, benzylpenicillin, ceftriaxone, cefpirome, cefotaxime, cefepime, cephaloridine and cefsulodin displayed no affinity to the transport system (K-i > 20 mM). The uptake into the cells and the transepithelial flux was highest for those beta-lactam antibiotics, which showed the strongest inhibition of [C-14]Gly-Sar transport (p < 0.0001). Exceptions were cefuroximaxetil and cephalotin. Conclusions. The probability of oral bioavailability for beta-lactam antibiotics is mainly determined by their affinity to PEPT1. A threshold K-i value of 14 mM with respect to Gly-Sar uptake is required.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 28 条
  • [11] UPTAKE AND TRANSEPITHELIAL TRANSPORT OF THE ORALLY ABSORBED CEPHALOSPORIN CEPHALEXIN, IN THE HUMAN INTESTINAL-CELL LINE, CACO-2
    GOCHOCO, CH
    RYAN, FM
    MILLER, J
    SMITH, PL
    HIDALGO, IJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (03) : 187 - 202
  • [12] INUI KI, 1988, J PHARMACOL EXP THER, V247, P235
  • [13] Peptide transporters in the intestine and the kidney
    Leibach, FH
    Ganapathy, V
    [J]. ANNUAL REVIEW OF NUTRITION, 1996, 16 : 99 - 119
  • [14] Molecular modeling study of structural requirements for the oligopeptide transporter
    Li, JB
    Hidalgo, IJ
    [J]. JOURNAL OF DRUG TARGETING, 1996, 4 (01) : 9 - +
  • [15] MATSUMOTO S, 1994, J PHARMACOL EXP THER, V270, P498
  • [16] TRANSPORT CHARACTERISTICS OF CEFTIBUTEN, A NEW ORAL CEPHEM, IN RAT INTESTINAL BRUSH-BORDER MEMBRANE-VESICLES - RELATIONSHIP TO OLIGOPEPTIDE AND AMINO BETA-LACTAM TRANSPORT
    MURANUSHI, N
    YOSHIKAWA, T
    YOSHIDA, M
    OGUMA, T
    HIRANO, K
    YAMADA, H
    [J]. PHARMACEUTICAL RESEARCH, 1989, 6 (04) : 308 - 312
  • [17] Structure and pharmacology of proton-linked peptide transporters
    Nussberger, S
    Steel, A
    Hediger, MA
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 46 (1-2) : 31 - 38
  • [18] Saitoh H, 1996, J PHARMACOL EXP THER, V278, P205
  • [19] SIMON C, 1989, ANTIBIOTIKA THERAPIE
  • [20] PENETRATION ENHANCEMENT FOR POLYPEPTIDES THROUGH EPITHELIA .D. ROUTES OF DELIVERY - CASE-STUDIES .5. ORAL ABSPORTION OF PEPTIDES AND PROTEINS
    SMITH, PL
    WALL, DA
    GOCHOCO, CH
    WILSON, G
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1992, 8 (2-3) : 253 - 290